GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikal Ltd (BOM:524735) » Definitions » Research & Development

Hikal (BOM:524735) Research & Development : ₹0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Hikal Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Hikal's Research & Development for the three months ended in Mar. 2024 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil.

Hikal Research & Development Historical Data

The historical data trend for Hikal's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikal Research & Development Chart

Hikal Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hikal Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hikal Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hikal  (BOM:524735) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Hikal Research & Development Related Terms

Thank you for viewing the detailed overview of Hikal's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Hikal (BOM:524735) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikal Ltd (BOM:524735) » Definitions » Research & Development
Comparable Companies
BOM:532300 BOM:506690 BOM:543748 BOM:532612 BOM:530549 BOM:509079 BOM:512529 BOM:524164 BOM:524372 BOM:524348 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
HIKAL:India
Address
Great Eastern Chambers, 6th Floor, Sector 11, CBD Belapur, Navi Mumbai, MH, IND, 400 614
Website
https://www.hikal.com
Hikal Ltd manufactures chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. Its products are distributed to pharmaceuticals, biotech, agrochemicals, and specialty chemical industries. Its segments include crop protection and pharmaceuticals. The majority of the revenue is derived from the pharmaceutical segment.

Hikal (BOM:524735) Headlines

No Headlines